Sangeeta N. Bhatia, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,750 shares at $152.05 ($266K) on 2018-06-04, disclosed to the SEC on 2018-06-05.
Open-market sale of $266k VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $152.05 | 875 | $133K | 50.0% |
| 2 | $152.05 | 875 | $133K | 50.0% |
| Total | $152.05 avg | 1,750 | $266K | 100% |
| Filing → |
| VRTX | SELL | 2025-08-29 | $206K | — | Filing → |
| VRTX | SELL | 2025-05-05 | $202K | — | Filing → |
| VRTX | SELL | 2024-09-04 | $323K | — | Filing → |